TruTouch Technologies is a pioneering company in the fields of biotechnology, information technology, and manufacturing. Founded in 2005 and headquartered in the United States, the company has gained recognition for its development and manufacturing of revolutionary technology for real-time measurement of the human body's condition. With over 20 years of research, 65 worldwide patents and patent applications, and extensive real-world testing, TruTouch's non-invasive, light-based devices have proven to offer fast and accurate results.
Notably, TruTouch is at the forefront of developing the next generation of alcohol detection sensors for vehicles through the DADSS (www.DADSS.org) program. Partnering with the National Highway Traffic Safety Administration (NHTSA) and the Automotive Coalition for Traffic Safety (ACTS), the company's technology is being integrated into vehicular components, expanding the applications of touch-based sensors.
The company received a Venture Round investment at 01 January 2019 from Omphalos Venture Partners, further solidifying its position as a leader in innovative biotechnology and information technology solutions.